ArticleFrontiers in molecular biosciences2026

TRIM2 suppresses prostate cancer progression by promoting ubiquitin-mediated degradation of DTNBP1.

Jiang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.